Literature DB >> 18055447

Widespread nonhematopoietic tissue distribution by transplanted human progenitor cells with high aldehyde dehydrogenase activity.

David A Hess1, Timothy P Craft, Louisa Wirthlin, Sarah Hohm, Ping Zhou, William C Eades, Michael H Creer, Mark S Sands, Jan A Nolta.   

Abstract

Transplanted adult progenitor cells distribute to peripheral organs and can promote endogenous cellular repair in damaged tissues. However, development of cell-based regenerative therapies has been hindered by the lack of preclinical models to efficiently assess multiple organ distribution and difficulty defining human cells with regenerative function. After transplantation into beta-glucuronidase (GUSB)-deficient NOD/SCID/mucopolysaccharidosis type VII mice, we characterized the distribution of lineage-depleted human umbilical cord blood-derived cells purified by selection using high aldehyde dehydrogenase (ALDH) activity with CD133 coexpression. ALDH(hi) or ALDH(hi)CD133+ cells produced robust hematopoietic reconstitution and variable levels of tissue distribution in multiple organs. GUSB+ donor cells that coexpressed human leukocyte antigen (HLA-A,B,C) and hematopoietic (CD45+) cell surface markers were the primary cell phenotype found adjacent to the vascular beds of several tissues, including islet and ductal regions of mouse pancreata. In contrast, variable phenotypes were detected in the chimeric liver, with HLA+/CD45+ cells demonstrating robust GUSB expression adjacent to blood vessels and CD45-/HLA- cells with diluted GUSB expression predominant in the liver parenchyma. However, true nonhematopoietic human (HLA+/CD45-) cells were rarely detected in other peripheral tissues, suggesting that these GUSB+/HLA-/CD45- cells in the liver were a result of downregulated human surface marker expression in vivo, not widespread seeding of nonhematopoietic cells. However, relying solely on continued expression of cell surface markers, as used in traditional xenotransplantation models, may underestimate true tissue distribution. ALDH-expressing progenitor cells demonstrated widespread and tissue-specific distribution of variable cellular phenotypes, indicating that these adult progenitor cells should be explored in transplantation models of tissue damage.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18055447      PMCID: PMC3045698          DOI: 10.1634/stemcells.2007-0429

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  54 in total

Review 1.  Endothelial progenitor cell culture for vascular regeneration.

Authors:  Masakazu Ishikawa; Takayuki Asahara
Journal:  Stem Cells Dev       Date:  2004-08       Impact factor: 3.272

Review 2.  Marrow stromal cells as stem cells for nonhematopoietic tissues.

Authors:  D J Prockop
Journal:  Science       Date:  1997-04-04       Impact factor: 47.728

3.  Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice.

Authors:  M Bhatia; J C Wang; U Kapp; D Bonnet; J E Dick
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

4.  Role for aldehyde dehydrogenase in survival of progenitors for murine blast cell colonies after treatment with 4-hydroperoxycyclophosphamide in vitro.

Authors:  E A Sahovic; M Colvin; J Hilton; M Ogawa
Journal:  Cancer Res       Date:  1988-03-01       Impact factor: 12.701

5.  Isolation of putative progenitor endothelial cells for angiogenesis.

Authors:  T Asahara; T Murohara; A Sullivan; M Silver; R van der Zee; T Li; B Witzenbichler; G Schatteman; J M Isner
Journal:  Science       Date:  1997-02-14       Impact factor: 47.728

6.  A single-base-pair deletion in the beta-glucuronidase gene accounts for the phenotype of murine mucopolysaccharidosis type VII.

Authors:  M S Sands; E H Birkenmeier
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

Review 7.  Mesenchymal stem cells and their potential as cardiac therapeutics.

Authors:  Mark F Pittenger; Bradley J Martin
Journal:  Circ Res       Date:  2004-07-09       Impact factor: 17.367

8.  Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer.

Authors:  J H Wolfe; M S Sands; J E Barker; B Gwynn; L B Rowe; C A Vogler; E H Birkenmeier
Journal:  Nature       Date:  1992 Dec 24-31       Impact factor: 49.962

9.  Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiency.

Authors:  E H Birkenmeier; M T Davisson; W G Beamer; R E Ganschow; C A Vogler; B Gwynn; K A Lyford; L M Maltais; C J Wawrzyniak
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

10.  Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain.

Authors:  E Y Snyder; R M Taylor; J H Wolfe
Journal:  Nature       Date:  1995-03-23       Impact factor: 49.962

View more
  30 in total

Review 1.  Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors.

Authors:  Todd Meyerrose; Scott Olson; Suzanne Pontow; Stefanos Kalomoiris; Yunjoon Jung; Geralyn Annett; Gerhard Bauer; Jan A Nolta
Journal:  Adv Drug Deliv Rev       Date:  2010-10-13       Impact factor: 15.470

Review 2.  The role of human aldehyde dehydrogenase in normal and cancer stem cells.

Authors:  Irene Ma; Alison L Allan
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

3.  Proliferating pancreatic beta-cells upregulate ALDH.

Authors:  Yinglan Liu; Xiaoxin Jiang; Yong Zeng; Hui Zhou; Jing Yang; Renxian Cao
Journal:  Histochem Cell Biol       Date:  2014-07-16       Impact factor: 4.304

4.  Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer.

Authors:  Yun Su; Qi Qiu; Xingqiao Zhang; Zhengran Jiang; Qixin Leng; Zhenqiu Liu; Sanford A Stass; Feng Jiang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02       Impact factor: 4.254

5.  Increased expression of ALDH1A1 protein is associated with poor prognosis in clear cell renal cell carcinoma.

Authors:  Kefeng Wang; Xiaonan Chen; Yunhong Zhan; Weiguo Jiang; Xuefeng Liu; Xia Wang; Bin Wu
Journal:  Med Oncol       Date:  2013-04-13       Impact factor: 3.064

6.  Identification and purification of mesodermal progenitor cells from human adult bone marrow.

Authors:  Mario Petrini; Simone Pacini; Luisa Trombi; Rita Fazzi; Marina Montali; Susumu Ikehara; Nader G Abraham
Journal:  Stem Cells Dev       Date:  2009 Jul-Aug       Impact factor: 3.272

7.  Human cord blood progenitors with high aldehyde dehydrogenase activity improve vascular density in a model of acute myocardial infarction.

Authors:  Claus S Sondergaard; David A Hess; Dustin J Maxwell; Carla Weinheimer; Ivana Rosová; Michael H Creer; David Piwnica-Worms; Attila Kovacs; Lene Pedersen; Jan A Nolta
Journal:  J Transl Med       Date:  2010-03-09       Impact factor: 5.531

8.  Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.

Authors:  Feng Jiang; Qi Qiu; Abha Khanna; Nevins W Todd; Janaki Deepak; Lingxiao Xing; Huijun Wang; Zhenqiu Liu; Yun Su; Sanford A Stass; Ruth L Katz
Journal:  Mol Cancer Res       Date:  2009-03-10       Impact factor: 5.852

9.  Targeted delivery of mesenchymal stem cells to the bone.

Authors:  Wei Yao; Nancy E Lane
Journal:  Bone       Date:  2014-08-28       Impact factor: 4.398

Review 10.  Contribution of human hematopoietic stem cells to liver repair.

Authors:  Ping Zhou; Louisa Wirthlin; Jeannine McGee; Geralyn Annett; Jan Nolta
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.